Insidersinvested$26.5mAn actualiMSCupdateI'm ashareholdermyselfWe willhaveexclusivityThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"Not manycompaniesthis size with2 late stageassetsWe haveenough cashto go wellinto 2023I/ONTAKis our leadassetMyron Holubiakand I founded aprivatecompany in2013Mino-Lokpotentialmarket>$1BAnymentionof Mino-WrapWe will openupinternationalsites forMino-Lok trialOur Halo-Lido trial willhave finalpatient byend of 2022We had aphase 2btrial with100%efficacyWe intendto submita BLA in2H 2022I/ONTAKwas thebest deal Iever madeI/ONTAK'spotentialmarket is>$300mI won't diluteshareholdersThere are noFDAapproveddrugs to treathemorrhoidsWe expect tofinish theMino-Loktrial this yearMino-Lokis our leadassetI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Only biotechwith 2 Myron'son theleadershipteamHemorrhoidsis a $2BmarketInsidersinvested$26.5mAn actualiMSCupdateI'm ashareholdermyselfWe willhaveexclusivityThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"Not manycompaniesthis size with2 late stageassetsWe haveenough cashto go wellinto 2023I/ONTAKis our leadassetMyron Holubiakand I founded aprivatecompany in2013Mino-Lokpotentialmarket>$1BAnymentionof Mino-WrapWe will openupinternationalsites forMino-Lok trialOur Halo-Lido trial willhave finalpatient byend of 2022We had aphase 2btrial with100%efficacyWe intendto submita BLA in2H 2022I/ONTAKwas thebest deal Iever madeI/ONTAK'spotentialmarket is>$300mI won't diluteshareholdersThere are noFDAapproveddrugs to treathemorrhoidsWe expect tofinish theMino-Loktrial this yearMino-Lokis our leadassetI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Only biotechwith 2 Myron'son theleadershipteamHemorrhoidsis a $2Bmarket

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Insiders invested $26.5m
  2. An actual iMSC update
  3. I'm a shareholder myself
  4. We will have exclusivity
  5. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  6. Not many companies this size with 2 late stage assets
  7. We have enough cash to go well into 2023
  8. I/ONTAK is our lead asset
  9. Myron Holubiak and I founded a private company in 2013
  10. Mino-Lok potential market >$1B
  11. Any mention of Mino-Wrap
  12. We will open up international sites for Mino-Lok trial
  13. Our Halo-Lido trial will have final patient by end of 2022
  14. We had a phase 2b trial with 100% efficacy
  15. We intend to submit a BLA in 2H 2022
  16. I/ONTAK was the best deal I ever made
  17. I/ONTAK's potential market is >$300m
  18. I won't dilute shareholders
  19. There are no FDA approved drugs to treat hemorrhoids
  20. We expect to finish the Mino-Lok trial this year
  21. Mino-Lok is our lead asset
  22. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  23. Only biotech with 2 Myron's on the leadership team
  24. Hemorrhoids is a $2B market